Zomedica Corp. Annual Cost of Revenue in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Zomedica Corp. quarterly/annual Cost of Revenue history and growth rate from 2020 to 2023.
  • Zomedica Corp. Cost of Revenue for the quarter ending June 30, 2024 was $1.77M, a 10.3% decline year-over-year.
  • Zomedica Corp. Cost of Revenue for the twelve months ending June 30, 2024 was $1.94M, a 71.6% decline year-over-year.
  • Zomedica Corp. annual Cost of Revenue for 2023 was $1.65M, a 69.8% decline from 2022.
  • Zomedica Corp. annual Cost of Revenue for 2022 was $5.46M, a 406% increase from 2021.
  • Zomedica Corp. annual Cost of Revenue for 2021 was $1.08M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.65M -$3.82M -69.8% Jan 1, 2023 Dec 31, 2023 10-Q 2024-05-09
2022 $5.46M +$4.38M +406% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.08M +$1.08M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.